Elevate Bio
formerly ElevateBioPowering the Creation of Genetic Medicines by ElevateBio
Elevate Bio was founded in 2019, is headquartered in Waltham, United States, lists 201–500 employees, and has $1.2B in recorded funding across 4 rounds.
- Headquarters
- Waltham, Massachusetts
- Employees
- 201–500
- Founded
- 2019
- Business Model
- B2B
- Website
- elevate.bio
- Total Funding
- $1.2B
- Last Round
- $401.0M Series DMay 2023
- Rounds
- 4
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 4 funding rounds and 8 investors for this company. The full record is or through the API.
About
ElevateBio is a technology-driven advanced therapy contract development and manufacturing organization (CDMO) that partners with biopharmaceutical companies to design, develop, and manufacture cell and gene therapies from early discovery through commercialization. The company provides proprietary gene editing tools and services, cGMP manufacturing capabilities, and end-to-end support across cell therapies, gene edited therapies, RNA therapies, and mRNA vaccines. Operating from its flagship facility in Waltham, Massachusetts, ElevateBio combines continuous investment in automation and AI-assisted design with integrated process development and manufacturing under one roof to reduce timelines and costs for partners. The company serves programs at all stages, from preclinical supply through pivotal trials, BLA filing, and commercial production.
Summary
Elevate Bio is a Biotech company based in Waltham, United States, founded in 2019. It lists 201–500 employees. It has raised $1.2B in total across 4 rounds, most recently a $401.0M Series D round in May 2023. Investors include SoftBank, Novo Nordisk and Woodline Partners.
Tech & App Stack
5 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
May 2023
Sign up to see all 4 events
Funding: Series A through Series D. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/elevate-bio"><img src="https://indexed.vc/api/badge/company/elevate-bio" alt="Elevate Bio on Indexed.vc" width="260" height="76" /></a>